Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 39,215 $ 45,719
Short-term restricted cash 528 655
Investments, available-for-sale 80,700 97,504
Receivables 10,646 9,195
Inventories 2,900 2,442
Prepaid and other current assets 5,092 3,306
Total current assets 139,081 158,821
Operating lease right-of-use assets 14,373 14,772
Property, plant and equipment, net 6,777 7,071
Goodwill and intangible assets, net 135 1,160
Long-term restricted cash 1,500 1,500
Other long-term assets 8,104 8,295
Total assets 169,970 191,619
LIABILITIES AND SHAREHOLDERS’ EQUITY    
Trade payables 3,285 6,921
Contract liabilities 10,966 10,348
Contract loss provisions 28,360 28,418
Accrued expenses and other current liabilities 5,945 5,602
Total current liabilities 48,556 51,289
Operating lease liabilities, non-current 13,483 13,921
Warrant liabilities 338 642
Other long-term liabilities 1,565 443
Total liabilities 63,942 66,295
Commitments and contingencies (Note 13)
Shareholders’ equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares outstanding as of March 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 500,000,000 shares authorized and 195,732,947 shares issued and outstanding (excluding restricted shares of 50,331) as of March 31, 2023; 192,924,429 shares issued and outstanding (excluding restricted shares of 59,770) as of December 31, 2022 19 19
Additional paid-in capital 425,590 434,478
Accumulated other comprehensive loss (457) (593)
Accumulated deficit (319,124) (308,580)
Total shareholders’ equity 106,028 125,324
Total liabilities and shareholders’ equity $ 169,970 $ 191,619